# Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development - AllSci

*Источник: AllSci*
*Дата: 2026-09-16*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPeS1CN3o1b1lWeE9ES0dtUXN2TkxXQWpOUXFyNThSRllWbS1CVjVESkhyNHpuVGYtOTdFZEstLXVQWXJmQmItdUV1aWQyOHJNNm9jR2xkbkdNOFBTTlE2R3B2OU0tcTFoU2MtWEhrWF9oU1hETjlLb2xRNFJobXBJV1pPRlJhUW9CQlVieDIzM0VNMzJObHVnSDVXNm1ITVVZam53?oc=5" target="_blank">Elvinix picks up Zealand's GLP-1/gastrin portfolio for type 1 diabetes development</a>&nbsp;&nbsp;<font color="#6f6f6f">AllSci</font>

[Оригинал](https://allsci.com/news/licensing-and-partnerships/type-1-diabetes-elvinix-secures-exclusive-license/)